Latest Fertiliser News

Agrimin Limited has received key environmental approval for its Mackay Potash Project while initiating a strategic review in response to sector challenges, alongside notable leadership changes.

Select Harvests Limited delivered a standout FY24 with a record almond crop and a significant NPAT turnaround, underpinned by strategic cost management and a successful $80 million capital raise. The company signals continued growth and operational improvements heading into FY25.

Environmental Clean Technologies Limited (ECT) has raised $750,000 through a two-tranche placement to fund its innovative COLDry Fertiliser Project and pursue strategic acquisitions, alongside key board changes.

Incitec Pivot Limited confirms its FY25 outlook remains steady despite operational hurdles at Phosphate Hill and a CFO transition, while progressing key strategic separations.

RLF AgTech Ltd has successfully raised approximately $2.42 million through an Entitlement Issue and Shortfall Placement, reflecting strong shareholder confidence in its turnaround strategy and growth prospects in Australia and Asia.

Vitrafy Life Sciences reports strong progress in cryopreservation technology development and US market expansion following a successful $35 million IPO. The company highlights improved biological sample preservation outcomes and strategic commercial milestones.

Vitrafy Life Sciences reported a dramatic increase in half-year losses to $25.7 million, yet successfully raised $35 million through an IPO to fuel its cryopreservation technology expansion.

RareX Limited's December 2024 Quarterly Report reveals significant progress in its Khaleesi Niobium and Mt Mansbridge Heavy Rare Earth projects, setting the stage for targeted drilling campaigns in 2025. The company also highlights strategic business development and sustainability initiatives.

Environmental Clean Technologies Limited has formed a joint venture and launched field trials for its innovative COLDry lignite-nitrogen fertiliser, marking a pivotal step toward commercialisation and revenue generation.

ABx Group reports significant progress in its rare earths and bauxite ventures, including enhanced geological models and pilot plant developments supported by key partnerships and government backing.

Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.

NeuRizer Ltd has resolved key regulatory delays for its NeuRizer Urea Project, significantly cut operating costs, and is forging international partnerships to expand its In Situ Gasification technology.